Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01774786
Title A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) and Chemotherapy in Patients With HER2-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Pertuzumab

Capecitabine + Cisplatin + Fluorouracil + Trastuzumab

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.